First clinical evaluation of the safety and efficacy of tarumase for the debridement of venous leg ulcers

Overview of attention for article published in International Wound Journal, February 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#33 of 1,224)
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 9 news outlets

Readers on

mendeley: 5 Mendeley

So far, Altmetric has seen 9 news stories from 9 outlets.

Demonstrated proof of concept for wound gel

Scientist Live, 04 Mar 2024

The results of a recent Phase IIa clinical trial conducted by biotechnology company SolasCure demonstrated a proof of concept…

SolasCure Publishes Phase IIa Clinical Trial Report in Leading Wound Care Journal

Morning Star, 04 Mar 2024

Publication in the ‘International Wound Journal’ provides robust validation of the Phase IIa trial data that will enable…

News story from Finanz Nachrichten on Monday 04 March 2024

Finanz Nachrichten, 04 Mar 2024

SolasCure Publishes Phase IIa Clinical Trial Report in Leading Wound Care Journal

Le Lézard, 04 Mar 2024

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound care, has today…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 5 additional news stories.